Technology Has A Role To Play As Research Adapts To New Constraints
Jiang Li, Ph.D., is the Founder and CEO of Vivalink, Inc.
Hybrid and decentralized clinical trials (DCTs) have been gaining momentum in recent years. Following the pandemic, sponsors and regulators increasingly adopted remote-friendly designs, regulatory agencies encouraged their adoption and digital health companies developed tools to facilitate these trials.
In 2023, the FDA issued draft guidance on DCTs that promoted the use of decentralized elements, such as remote data collection, telehealth visits and wearable sensors, to enhance trial flexibility, efficiency and inclusivity. This guidance was finalized in September 2024, solidifying the FDA's support for incorporating decentralized elements in clinical trials.
Policy shifts threaten progress.
That momentum is now under pressure. The National Institutes of Health (NIH) funds the bulk of medical research in the U.S. But a new federal policy would cap overhead reimbursement at 15%, reducing indirect cost support for many research centers and potentially reshaping how academic science is funded.
Plus, the Department of Health and Human Services has begun cutting nearly 10,000 employees and plans to eliminate a total of 20,000 positions. The layoffs, part of a sweeping restructuring effort, have already impacted core health agencies like the NIH and FDA. As a result, trials have been paused, grants delayed and many research institutions, including major universities and academic medical centers, have reduced staff or scaled back operations.
These shifts have posed major challenges for the implementation of DCTs in academic and early-stage research, where adoption was just beginning to gain traction. With fewer staff and less funding, institutions face greater barriers to adopting and managing the technologies essential to decentralized trial models.
Yet regulatory support for DCTs, and the need for efficient and accessible trials, haven't gone away. Technology alone can't offset these setbacks, but it can help support ongoing research by reducing operational burden, enabling remote participation and helping sponsors manage studies with fewer resources.
Prioritize interoperability.
The increased application of DCTs has introduced a growing array of tools into how research is conducted, including wearables, remote monitoring devices, telehealth platforms, mobile apps and dashboards. But as academic institutions and research centers face staffing cuts and constrained budgets, managing a patchwork of disconnected systems is increasingly unsustainable.
This environment heightens the need to prioritize interoperability. Even before these changes, sponsors were leaning toward solutions that integrate easily into their existing workflows. Now, they're looking for platforms that reduce the operational burden on already stretched teams.
Interoperability should be a core design consideration. Solutions that connect with EHRs, lab systems, participant-reported outcomes and sponsor dashboards can reduce friction, cut down on manual processes and allow research teams to focus on science instead of system management.
Equally important are ready-to-use mobile apps and connected devices that require minimal setup or IT support. Planning for integration early, both across systems and devices, can help trials run more efficiently as organizations adapt to doing more with less.
Deliver measurable impact.
With tighter budgets and increased scrutiny, sponsors need to justify every dollar. That means technology must deliver clear and measurable results, whether by accelerating recruitment, improving retention, reducing site visits or producing more complete datasets.
Flexibility is just as important. As trials evolve, sponsors need platforms that can adapt, such as being able to adjust mid-study, support multiple arms or accommodate late-stage protocol changes. Tools that can be configured on the fly or deployed across different trial designs help teams stay responsive when timelines shift or priorities change.
Real-time monitoring and continuous data collection are shifting how sponsors track progress during a trial. These technologies often surface early insights and preliminary findings faster than traditional timelines would. As a result, teams now have an opportunity to adjust mid-study, including changes to the study design, resource allocation or cohort size.
A recent study highlighted this need for adaptability, pointing to modular digital platforms as a way for sponsors to retain control when trial activities shift. But it also made clear that technology alone isn't enough.
As these platforms evolve, clinical and technical teams will need to work together to build solutions that meet the needs of everyone involved, from investigators and sponsors to participants. Technology providers that offer both measurable impact and flexibility, without locking sponsors into rigid ecosystems, are better positioned to support research teams under pressure.
Support what remains.
Recent funding cuts are disrupting the infrastructure supporting early-stage and academic research, from lab space and shared equipment to staff and resources. While technology can't reverse these cuts, it can support the trials that continue and help sponsors maintain critical metrics like participant adherence.
Studies have shown that technology solutions like remote monitoring and digital platforms can increase patient adherence. For example, a recent study using electronic diaries resulted in compliance rates of up to 94%, compared to just 11% with paper diaries. Another study found that remote patient monitoring has been proven to improve adherence to medications and lifestyle changes.
Platforms that can track adherence in real time, send automated reminders and flag protocol deviations give research teams the visibility they need to act quickly. These systems can alert teams when a participant's device isn't sending data as expected, track whether devices are being used correctly and help staff identify participants who may need follow-up. With fewer team members and more limited oversight, access to this information is important.
As research institutions shift from growth to preservation, technology is playing a more functional role. Technology can't replace the research that's been paused or the teams that have been downsized, but it can help keep ongoing trials on track. That includes maintaining data quality, flagging issues early and helping teams follow up when participants miss visits or fall behind.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Pure-Play Quantum in Focus: IONQ, QBTS Shine, RGTI a Wait-and-See
Quantum computing has long promised a leap in processing power beyond classical limits. The spotlight on this niche sector has intensified recently, with NVIDIA's NVDA CEO Jensen Huang declaring that quantum computing is reaching an 'inflection point,' a sharp shift from his earlier stance that practical use was decades away. Meanwhile, International Business Machines IBM unveiled an ambitious roadmap targeting a large-scale, fault-tolerant quantum computer (codenamed Starling) by 2029. Against this backdrop, investors are increasingly exploring pure-play opportunities in the sector. Three publicly listed quantum firms, IonQ IONQ, D-Wave Quantum QBTS and Rigetti Computing RGTI, have emerged with their distinct strategies and progress. Their last-reported first-quarter 2025 earnings reveal how each is advancing on technology, revenues and financial stability. Image Source: Zacks Investment Research Let's delve deeper. One of IonQ's recent milestones is the $22 million sale of 50% compute capacity from its Forte Enterprise system to EPB Chattanooga, marking the industry's first commercial deployment that combines a quantum network and quantum computer. IonQ announced a series of strategic acquisitions to strengthen its technological edge — the $1.1 billion acquisition of Oxford Ionics (noted outside the earnings call) and the planned purchases of Lightsynq and Capella, which are expected to enhance capabilities in photonic interconnects, quantum repeaters and space-based quantum communication. The company also signed MOUs with Toyota Tsusho, Japan's AIST (G-QuAT division), and satellite tech firm Intellian to explore quantum key distribution in space. IonQ was also selected to participate in DARPA's Quantum Benchmarking Initiative, further validating its leadership in advancing measurable quantum performance. This Zacks Rank #2 (Buy) stock is currently trading 27.6% below its 52-week high of $54.74, which offers a potential upside for new buyers. The Zacks Consensus Estimate for IonQ's 2025 earnings implies a 69.9% improvement over 2024. Image Source: Zacks Investment Research D-Wave Quantum, known for its annealing-based quantum systems, delivered strong first-quarter 2025 financial performance and achieved technical milestones. The company's first-quarter revenues were up 509% year over year, driven largely by a system sale to the Julich Supercomputing Center. Adjusted gross margin surged to 93.6%, while net loss narrowed to $5.4 million, the company's lowest since going public. On the technology front, D-Wave claimed quantum supremacy by simulating a magnetic material problem that would take even the world's most powerful classical supercomputer millions of years to solve. Its new Advantage2 system, featuring over 4,400 qubits, a 40% increase in energy scale, and enhanced 20-way qubit connectivity, showcased substantial performance gains. QBTS, a Zacks Rank #2 stock, is currently trading 20.5% below its 52-week high of $19.76. The Zacks Consensus Estimate for D-Wave's 2025 earnings implies a 72% improvement year over year. Image Source: Zacks Investment Research Rigetti Computing is advancing with its gate-based superconducting quantum architecture, prioritizing scalability and error correction. Key wins include selection for DARPA's Quantum Benchmarking Initiative and a $5.48 million AFOSR-led project to advance its ABAA chip fabrication technology. In the United Kingdom, Rigetti secured three Quantum Mission Pilot Awards focused on real-time quantum error correction with partners like Riverlane and NQCC. A research breakthrough, published in Nature Physics, demonstrated optical control of superconducting qubits, potentially easing cryogenic scaling constraints. However, compared to the other two startups, investors are a bit apprehensive about the stock's near-term growth momentum. This is because its first-quarter 2025 revenues declined to $1.5 million from $3.1 million in the year-ago period. Gross margin was 30%, down from 49% in the year-ago period. Despite near-term challenges, RGTI's sustained R&D momentum and strategic backing signal potential for massive growth as the industry matures. This stock is currently trading 47% below its 52-week high of $21.42. The Zacks Consensus Estimate for Rigetti's 2025 earnings implies an 86.1% improvement year over year. Image Source: Zacks Investment Research Given the current momentum and first-quarter performance, IonQ and D-Wave Quantum stand out as the stronger investment options among the three. Both companies have achieved significant technical and financial milestones, including major system sales, strategic partnerships and strong revenue growth. While IonQ is gaining strength through acquisitions, D-Wave is demonstrating quantum supremacy. In contrast, Rigetti, with a Zacks Rank #4 (Sell), is facing revenue declines and margin compression, making it a less favorable choice for near-term investors despite its long-term potential. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report International Business Machines Corporation (IBM) : Free Stock Analysis Report NVIDIA Corporation (NVDA) : Free Stock Analysis Report IonQ, Inc. (IONQ) : Free Stock Analysis Report Rigetti Computing, Inc. (RGTI) : Free Stock Analysis Report D-Wave Quantum Inc. (QBTS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
CBS News
26 minutes ago
- CBS News
Allegheny County issues code red heat advisory due to impending heat wave
Allegheny County will activate a code red heat advisory beginning Sunday, June 22, through Wednesday, June 25, due to extreme forecasted heat that could pose risks to vulnerable residents. The activation is based on the National Weather Service and Centers for Disease Control's HeatRisk tool, which considers how unusual and prolonged the heat is for this time of year, as well as the potential for serious health impacts, according to a provided news release from county officials. "We've always responded to heat emergencies, but this year we're being more systematic," said Erin Dalton, Director of the Allegheny County Department of Human Services. "Senior centers will now more consistently extend their hours on Code Red days, and we'll be assessing conditions to potentially expand overnight shelter when extreme heat persists into the night. This pilot approach will help us learn what works best to keep people safe." Residents are encouraged to check on neighbors, friends, and family, especially those who are older or medically vulnerable. Allegheny County Emergency Services is reminding residents that heat is the leading weather-related cause of death nationwide, surpassing the fatalities caused by floods, tornadoes, hurricanes, and lightning. Tips to keep yourself safe during extreme heat include drinking plenty of water to stay hydrated, even if you are not thirsty; keeping cool by using wet towels, putting feet in cool water, and taking cool showers; spend as much time as possible in cool or air-conditioned buildings; staying out of the sun during the hottest part of the day; wear sunscreen and hats with other loose-fitting clothing; and never leave pets or children in vehicles. Cooling centers opening In response to the forecasted temperatures, CitiParks will open six cooling centers on Sunday, June 22, through Wednesday, June 25. When operating as a cooling center, senior centers will welcome residents of any age. The Department of Human Services is also taking additional actions, including outreach to older adults, children, and people experiencing homelessness, in coordination with the City of Pittsburgh and other municipalities, according to a news release. On Sunday, cooling centers will be open from 12 p.m. to 6 p.m. From Monday through Wednesday, the centers will operate from 8 a.m. to 7 p.m. A full list of operational cooling centers is below. Beechview Healthy Active Living Community Center 1555 Broadway Avenue Pittsburgh, Pa. 15216 Brighton Heights Healthy Active Living Community Center 3515 McClure Avenue Pittsburgh, Pa. 15212 Greenfield Healthy Active Living Community Center 745 Greenfield Avenue Pittsburgh, Pa. 15217 Homewood Healthy Active Living Community Center 7321 Frankstown Road Pittsburgh, Pa. 15208 Sheraden Healthy Active Living Community Center 720 Sherwood Avenue Pittsburgh, Pa. 15204 South Side Healthy Active Living Community Center 12th and Bingham Streets Pittsburgh, Pa. 15203
Yahoo
33 minutes ago
- Yahoo
Nvidia (NVDA) Could Hit $5 Trillion as Analysts Lift Price Targets
Nvidia (NVDA, Financials) is drawing fresh bullish forecasts after a rapid five-year rally, with analysts now predicting the chipmaker could grow into a $5 trillion company. Warning! GuruFocus has detected 4 Warning Signs with NVDA. Shares have climbed more than 3,000% over the past five years, and are currently trading near all-time highs. Rosenblatt Securities analyst Hans Mosesmann maintained a $200 price target this week, while UBS and Goldman Sachs pointed to Nvidia's dominant position in AI hardware as reason for long-term upside. Nvidia controls more than 80% of the AI accelerator market and reported a 427% year-over-year jump in data center revenue in its latest quarter. That segment is critical to generative AI and cloud infrastructure buildouts, bolstering Nvidia's top line and free cash flow which now exceeds Amazon's. The company's proprietary CUDA software, tight integration with Taiwan Semiconductor Manufacturing Co., and leading-edge GPUs like the H100 and upcoming Blackwell series reinforce its pricing power and market moat. Nvidia also reported more than $14 billion in quarterly profits, helping justify its $2.9 trillion market cap as of June 18. A doubling in valuation would place it in direct competition with Apple (AAPL, Financials) and Microsoft (MSFT, Financials) as the world's most valuable public firm. Nvidia trades at over 40x forward earnings, raising valuation concerns. Analysts are also monitoring geopolitical tensions between the U.S. and China, which could impact Nvidia's chip exports and manufacturing pipeline. Advanced Micro Devices (AMD, Financials) and Intel (INTC, Financials) continue to invest in AI chips, although they currently trail Nvidia on execution. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
